NCT01782924View on ClinicalTrials.gov

A Phase 3 Clinical Study of KHK4827

PHASE3CompletedINTERVENTIONAL
Enrollment

145

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Psoriasis
Interventions
DRUG

KHK4827

Trial Locations (1)

100-8185

For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin, Chiyoda-ku

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT01782924 - A Phase 3 Clinical Study of KHK4827 | Biotech Hunter | Biotech Hunter